Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Diadem
company
About
Diadem is an innovative blood-based test exploiting a proprietary antibody targeting a specific conformation of p53 protein.
- 1 - 10
Details
- Last Funding Type
- Debt Financing
- Last Funding Money Raised
- €7.50M
- Industries
- Therapeutics
- Founded date
- Jun 1, 2012
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Diadem is an innovative blood-based test exploiting a proprietary antibody targeting a specific conformation of p53 protein.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
€7.50M
Diadem has raised a total of
€7.50M
in funding over 2 rounds. Their latest funding was raised on
Mar 7, 2022 from a Debt Financing round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 7, 2022 | Debt Financing | €7.50M | 1 |
European Investment Bank
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Diadem is funded by 1 investors.
European Investment Bank
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
European Investment Bank
|
Yes | Debt Financing |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
